Novartis AG
NVS • Drug Manufacturers - General
$153.64
▲ +0.03 (+0.02%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHLY FAVORABLE PROFILEExcellentConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$293.91B
Growth
4.6%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 25.6%Positive revenue growth · 9.6%Positive free cash flow · 9.12Consistent free cash flow · 5/5Reasonable earnings multiple · 19.02
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Apr 28, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$153.64
Change0.02%
Shares Out1.92B
Market Cap$293.91B
Enterprise Value$332.00B
52W Range112.34 - 170.46
Beta0.49
P/E21.72
P/S5.24
P/B7.63
P/FCF17.17
EV/Sales5.92
Price$153.64
Change0.02%
Shares Out1.92B
Market Cap$293.91B
Enterprise Value$332.00B
52W Range112.34 - 170.46
Beta0.49
P/E21.72
P/S5.24
P/B7.63
P/FCF17.17
EV/Sales5.92
EV/EBITDA14.82
EV/FCF19.40
Earnings Yield4.60%
FCF Yield5.82%
Dividend Yield2.96%
Gross Margin75.02%
Oper. Margin31.15%
Profit Margin25.64%
Debt/Eq0.80
Current Ratio1.12
Quick Ratio0.89
Revenue 5Y4.59%
FCF 5Y7.97%
Target$146.00
Target Upside-4.97%
Target Median$146.00
Target Range136.00 - 156.00
Volume2.01M
Avg Volume1.64M
EPS Surprise-0.12
Investment DNA
How strong this company looks for long-term investors
82
out of 100
Business Quality
Margins, moat, returns
77/100
Financial Strength
Debt, cash, stability
69/100
Growth Potential
Revenue and expansion
94/100
Price Attractiveness
Cheap or expensive today
68/100
Why this score▼
Stable or improving margins · 25.6%Positive revenue growth · 9.6%Positive free cash flow · 9.12Consistent free cash flow · 5/5Reasonable earnings multiple · 19.02Manageable debt level · 0.8
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 25 analyst votes · 2026-10-20
58/100
Neutral
Bullish
6
Hold
17
Bearish
2
Price Target
2026-06-12
Low
$170.00
Mean
$170.00
Median
$170.00
High
$170.00
🧾
No insider activity
No recent insider transactions available.